In This Article:
BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $64.1 million in its first quarter.
On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 38 cents. Losses, adjusted for non-recurring costs, came to 37 cents per share.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The biotechnology company posted revenue of $10.7 million in the period, also missing Street forecasts. Five analysts surveyed by Zacks expected $17.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL